Short answer · Medically reviewed summary · Last updated: 2023-07-13
Hyperprolinemia Type II is a rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by a deficiency of the enzyme pyrroline-5-carboxylate reductase (P5CR), which is responsible for the conversion of pyrroline-5-carboxylate (P5C) to proline. As a genetic disorder, Hyperprolinemia Type II is indeed hereditary.
Is Hyperprolinemia Type II hereditary?
Is Hyperprolinemia Type II hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Hyperprolinemia Type II is a rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by a deficiency of the enzyme pyrroline-5-carboxylate reductase (P5CR), which is responsible for the conversion of pyrroline-5-carboxylate (P5C) to proline.
As a genetic disorder, Hyperprolinemia Type II is indeed hereditary. It is inherited in an autosomal recessive manner, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent, in order to develop the condition. If both parents are carriers of the mutated gene, there is a 25% chance with each pregnancy that their child will have Hyperprolinemia Type II.
It is important to note that carriers of the mutated gene typically do not show any symptoms of the disorder. However, they have a 50% chance of passing the mutated gene to their children. Genetic testing can be performed to determine carrier status and assess the risk of having a child with Hyperprolinemia Type II.
While there is currently no cure for Hyperprolinemia Type II, management of the condition focuses on reducing proline levels through dietary modifications and supplementation. Regular monitoring and follow-up with healthcare professionals are essential to ensure optimal management and to address any potential complications that may arise.
